Ginkgo Bioworks Holdings DNA
NYSE DNA
$7.84 +0.78 (+11.05%)
As of: Sep 17, 2026 · 3:59 PM EDT

Ginkgo Bioworks Holdings (DNA) Net Margin (QoQ) (2020 - 2026)

Analysis

Ginkgo Bioworks Holdings (DNA) Net Margin (QoQ) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19,235.00
Mar 31, 2026 -18,229.00
Dec 31, 2025 -3,387.00
Sep 30, 2025 -5,385.00
Jun 30, 2025 8,383.00
Mar 31, 2025 733.00
Dec 31, 2024 -18,191.00
Sep 30, 2024 32,306.00
Jun 30, 2024 5,085.00
Mar 31, 2024 -35,017.00
Dec 31, 2023 45,935.00
Sep 30, 2023 -33,132.00
Jun 30, 2023 3,887.00
Mar 31, 2023 -7,788.00
Dec 31, 2022 83,317.00
Sep 30, 2022 -54,558.00
Jun 30, 2022 -11,304.00
Mar 31, 2022 73,020.00
Dec 31, 2021 -94,890.00
Sep 30, 2021 -713.00